Stock Events

Stock Events

Merck & 

€121.6
9135
+€0+0% Friday 10:31

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
300.64B
P/E Ratio
31.51
Dividend Yield
2.39%
Dividend
2.91

Upcoming

16
JUN
Dividend Ex
Estimated
 
8
JUL
Dividend Payment
Estimated
 
15
SEP
Dividend Ex
Estimated
 
7
OCT
Dividend Payment
Estimated
 
15
DEC
Dividend Ex
Estimated
 

Dividends

2.39%Dividend Yield
Apr 26
€0.74
Jan 26
€0.72
Oct 25
€0.69
Jul 25
€0.7
Apr 25
€0.74
10Y Growth
3.9%
5Y Growth
5.19%
3Y Growth
4.73%
1Y Growth
3.66%

Earnings

4AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-1.47
-0.12
1.23
2.58
Expected EPS
2.079965
Actual EPS
N/A

Financials

0.89%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
55.41BRevenue
494.99MNet Income

Analyst Ratings

96.62Average Price Target
The highest estimate is 110.03.
From 15 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MRK.PA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer competes directly with Merck in various therapeutic areas, including vaccines and oncology.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical segment, competes in areas such as immunology and cancer treatments.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline competes with Merck in the vaccines market and respiratory diseases.
Novartis
NVS
Mkt Cap279.67B
Novartis competes in multiple areas including oncology, neuroscience, and cardiovascular health.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie competes with Merck in areas such as immunology and oncology, particularly with its Humira product.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb competes in the oncology space, directly challenging Merck's Keytruda with its Opdivo.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly competes in the diabetes and cancer treatment markets, areas of focus for Merck.
AMGEN
AMGN
Mkt Cap178B
Amgen competes with Merck in areas such as oncology and cardiovascular diseases.
Roche
RHHBY
Mkt Cap328.49B
Roche, through its Genentech subsidiary, competes in oncology, including direct competition in the PD-L1 inhibitor space.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes with Merck in the diabetes, cardiovascular, and vaccines markets.

About

There is no Profile data available for 6MK.SG.
Show more...
CEO
Mr. Robert M. Davis J.D.
Employees
67000
Country
United States
ISIN
US58933Y1055
WKN
000A0YD8Q

Listings

NEO
CA
MRK.NEO
TO
CA
MRK.TO
SN
CL
MRK.SN
XETRA
DE
6MK.XETRA

0 Comments

Share your thoughts

FAQ

What is Merck & stock price today?▼
The current price of MRK.PA is €121.6 EUR — it has increased by +0% in the past 24 hours. Watch Merck & stock price performance more closely on the chart.
What is Merck & stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Merck & stocks are traded under the ticker MRK.PA.
What is Merck & market cap?▼
Today Merck & has the market capitalization of 300.64B
What is Merck & revenue for the last year?▼
Merck & revenue for the last year amounts to 55.41B EUR.
What is Merck & net income for the last year?▼
MRK.PA net income for the last year is 494.99M EUR.
Does Merck & pay dividends?▼
Yes, MRK.PA dividends are paid quarterly. The last dividend per share was 0.78 EUR. As of today, Dividend Yield (FWD)% is 2.39%.
How many employees does Merck & have?▼
As of May 05, 2026, the company has 67,000 employees.
In which sector is Merck & located?▼
Merck & operates in the Health & Wellness sector.
When did Merck & complete a stock split?▼
Merck & has not had any recent stock splits.
Where is Merck & headquartered?▼
Merck & is headquartered in Kenilworth, United States.